The FDA has approved Sisnos’s continuous glucose monitoring (CGM) system for consumer use beyond diabetes management, including weight management support. The device offers real-time glucose tracking ...
Share on Pinterest The Signos system can be used alone, in combination with, or after GLP-1 drugs or bariatric surgery. Photography courtesy of Signos The FDA cleared the first glucose monitoring ...
The FDA approved the first over-the-counter glucose monitoring system designed to help with weight management. Developed by health technology company Signos, the system combines the Stelo by Dexcom ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback